Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/1995
09/14/1995CA2184687A1 Humanized milk
09/14/1995CA2184686A1 Transgenic production of oligosaccharides and glycoconjugates
09/14/1995CA2184583A1 Transforming growth factor alpha h1
09/14/1995CA2184498A1 Extracorporeal cell culture and transplantation kits
09/14/1995CA2184358A1 Glioblastoma-derived angiogenesis inhibiting factor
09/14/1995CA2183963A1 Dirofilaria immitis gp29 proteins, nucleic acid molecules and uses thereof
09/14/1995CA2183961A1 Fibroblast growth factor-10
09/14/1995CA2183644A1 Synthetic proteins as implantables
09/14/1995CA2183568A1 Insect neuropeptides
09/14/1995CA2180353A1 Antimicrobial proteins from aralia and impatiens
09/13/1995EP0671473A1 Method for suppressing inhibition of enzyme-mediated reactions by ionic detergents
09/13/1995EP0671472A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody
09/13/1995EP0671471A1 Process for producing foreign protein
09/13/1995EP0671470A2 Trehalose releasing enzyme, DNA encoding therefor, their preparation and uses
09/13/1995EP0671005A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
09/13/1995EP0670907A1 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria.
09/13/1995EP0670905A1 Recombinant viruses displaying a nonviral polypeptide on their external surface
09/13/1995EP0670904A1 Vector for the expression of therapy-relevant genes
09/13/1995EP0670903A1 Medium-chain thioesterases in plants
09/13/1995EP0670902A1 cDNA CLONE FOR HUMAN INDUCIBLE NITRIC OXYDE SYNTHASE AND PROCESS FOR PREPARING SAME
09/13/1995EP0670901A1 Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
09/13/1995EP0670900A1 Bacillus thuringiensis isolates active against lepidopteran pests
09/13/1995EP0670899A1 Heat shock proteins and the treatment of tumours
09/13/1995EP0670898A1 Interleukin-3 (il-3) mutant polypeptides
09/13/1995EP0670897A1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE
09/13/1995EP0670896A1 Cloning and expression of biologically active alpha-galactosidase a
09/13/1995EP0670895A1 Cloning, expression and uses of a novel secreted protein, f-spondin
09/13/1995EP0670893A1 Novel enzyme preparations and methods for their production
09/13/1995EP0670848A1 High molecular weight collagen-like protein polymers
09/13/1995EP0670847A1 Subtilin variant of enhanced stability and activity
09/13/1995EP0670733A1 Compositions containing growth factors and antiplastic agents
09/13/1995EP0670730A1 Fusion proteins comprising tumor necrosis factor receptor
09/13/1995EP0670670A1 Transgenic cotton plants producing heterologous peroxidase
09/13/1995EP0661979A4 Cross-linking oligonucleotides for enzyme-mediated triple strand formation.
09/13/1995EP0566685B1 METHOD OF DESCRIBING REPERTOIRES OF ANTIBODIES (Ab) AND T CELL RECEPTORS (TcR) OF THE IMMUNE SYSTEM OF AN INDIVIDUAL
09/13/1995EP0542869B1 Tissue plasminogen activator variants with decreased clearance
09/13/1995EP0475936B1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex
09/13/1995EP0426843B1 Nucleic acid probes for the detection of neisseria gonorrhoeae
09/13/1995EP0383770B1 Inhibition of eucaryotic pathogens and neoplasms with lytic peptides
09/13/1995EP0328829B1 Method for affinity assays using target amplification
09/13/1995CN1108457A New lipase variants for use in detergent applications
09/13/1995CN1108306A Reconstituted hepatitis B vaccine with corboxy end having anterior surface antigen 1 determinant
09/13/1995CN1108303A Prepn. of reconstituted human granulocyte-macrophage colony stimulating factor
09/13/1995CN1108217A Method for prepn. of tungsten bullet of gene gun for transfering external gene
09/12/1995US5449766 DNA encoding NEI and NGE peptides
09/12/1995US5449765 DNA encoding amino acids 590-710 of glycoprotein gII of pseudorabies virus
09/12/1995US5449764 Controlling fruit ripening
09/12/1995US5449758 Gel electrophoresis
09/12/1995US5449755 Human cyclin E
09/12/1995US5449753 Autotaxin: motility stimulating protein useful in cancer diagnosis
09/12/1995US5449614 Recombinant retroviruses with amphotropic and ecotropic host ranges
09/12/1995US5449608 Detection
09/12/1995US5449606 DNA encoding neuronal nicotinic acetylcholine receptor compositions containing the beta 4 subunit
09/12/1995US5449602 Polynucleotides
09/12/1995CA2123751A1 Self-incompatibility genes associated with the a10 allele
09/08/1995WO1995023875A1 In vitro transposition of artificial transposons
09/08/1995WO1995023874A1 Determination of cancerous conditions by mage gene expression
09/08/1995WO1995023868A1 Production of fibrinogen in transgenic animals
09/08/1995WO1995023867A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
09/08/1995WO1995023866A1 Vector for liver-specific gene therapy
09/08/1995WO1995023865A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
09/08/1995WO1995023864A1 Process for producing l-lysine
09/08/1995WO1995023863A1 Dna constructs, cells and plants derived therefrom
09/08/1995WO1995023862A1 Animals with targeted gene disruption
09/08/1995WO1995023861A1 HUMAN MEGAKARYOCYTOPOIETIN AND ISOLATION THEREOF, cDNA CLONING, AND PREPARATION OF THE RECOMBINANT PROTEIN
09/08/1995WO1995023860A2 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR
09/08/1995WO1995023859A2 Novel forms of t cells costimulatory molecules and uses therefor
09/08/1995WO1995023858A1 A novel voltage-gated potassium channel gene
09/08/1995WO1995023857A1 Yeast strains and modified albumins
09/08/1995WO1995023856A1 Chimeric complement inhibitor proteins
09/08/1995WO1995023855A2 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995WO1995023849A1 Novel protein-kinase, nucleic acid sequences encoding the same and methods related thereto
09/08/1995WO1995023846A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins
09/08/1995WO1995023844A1 A method of transformation of nocardia
09/08/1995WO1995023814A1 Product and process for t cell regulation
09/08/1995WO1995023813A1 In vitro antibody affinity maturation using alanine scanning mutagenesis
09/08/1995WO1995023611A1 Products comprising substrates capable of enzymatic cross-linking
09/08/1995WO1995023512A1 Terminal complement inhibitor fusion genes and proteins
09/08/1995WO1995022609A3 Human glutamate receptor proteins
09/08/1995WO1995021927A3 Targeting gene therapy
09/08/1995WO1995021916A3 Pp32: a newly identified cd45-associated protein
09/08/1995WO1995019429A3 Method and reagent for inhibiting hepatitis c virus replication
09/08/1995WO1995014099A3 Process for protein production in plants
09/08/1995CA2309891A1 Production of fibrinogen in transgenic animals
09/08/1995CA2184810A1 Product and process for t cell regulation
09/08/1995CA2184707A1 Animals with targeted gene disruption
09/08/1995CA2184580A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995CA2184482A1 Determination of cancerous conditions by mage gene expression
09/08/1995CA2184356A1 Terminal complement inhibitor fusion genes and proteins
09/08/1995CA2184355A1 Chimeric complement inhibitor proteins
09/08/1995CA2184354A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins
09/08/1995CA2184277A1 Novel forms of t cells costimulatory molecules and uses therefor
09/08/1995CA2184113A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
09/08/1995CA2184058A1 Kunitz domain inhibitor proteins derived from alzheimer's amyloid .beta.-protein precursor inhibitor
09/08/1995CA2183643A1 Products comprising substrates capable of enzymatic cross-linking
09/08/1995CA2183550A1 In vitro antibody affinity maturation using alanine scanning mutagenesis
09/08/1995CA2182951A1 A method of transformation of nocardia
09/08/1995CA2181787A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
09/08/1995CA2161767A1 In vitro transposition of artificial transposons
09/07/1995DE4414185C1 Sequences for proteins with saccharose-isomerase activity
1 ... 3745 3746 3747 3748 3749 3750 3751 3752 3753 3754 3755 3756 3757 3758 3759 3760 3761 3762 3763 3764 3765 ... 4023